1. Home
  2. Analysis
  3. Gilenya
  4. Viral-vasculitis

Gilenya and Viral vasculitis - a phase IV clinical study of FDA data

Summary:

Viral vasculitis is reported as a side effect among people who take Gilenya (fingolimod), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Acyclovir, and have Herpes zoster.

The phase IV clinical study analyzes which people have Viral vasculitis when taking Gilenya. It is created by eHealthMe based on reports of 111,612 people who have side effects when taking Gilenya from the FDA, and is updated regularly.

What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.

What is Viral vasculitis?

Viral vasculitis (inflammation of blood vessels caused by viruses) is found to be associated with 11 drugs and 17 conditions by eHealthMe. Check the latest studies of Viral vasculitis.

On Jul, 15, 2026

111,612 people reported to have side effects when taking Gilenya.
Among them, 16 people (0.01%) have Viral vasculitis.

Could Gilenya cause Viral vasculitis?

Among these 16 people:

How long have people been on Gilenya when they have Viral vasculitis? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 92.31 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 7.69 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Viral vasculitis when taking Gilenya? *

  • female: 7.69 %
  • male: 92.31 %

What is the age of people who have Viral vasculitis when taking Gilenya? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 91.67 %
  • 60+: 0.0 %

What are other drugs people take besides Gilenya? *

  1. Acyclovir: 2 people, 12.50%
  2. Cubicin: 1 person, 6.25%
  3. Avonex: 1 person, 6.25%

What are other side effects people have besides Viral vasculitis? *

  1. Herpes Zoster: 13 people, 81.25%
  2. Hypotension (abnormally low blood pressure): 12 people, 75.00%
  3. Blood Creatinine Increased: 12 people, 75.00%
  4. Blood Urea Increased: 12 people, 75.00%
  5. Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 12 people, 75.00%
  6. Consciousness - Decreased: 12 people, 75.00%
  7. Csf Test Abnormal: 12 people, 75.00%
  8. Herpes Dermatitis (skin inflammation caused by a herpes simplex virus (hsv)): 12 people, 75.00%
  9. Acute Kidney Failure: 12 people, 75.00%
  10. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 12 people, 75.00%

What are the existing conditions these people have? *

  1. Herpes Zoster: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Gilenya and have Viral vasculitis?

- Check whether Viral vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gilenya:

Viral vasculitis treatments and more:

How severe was Viral vasculitis and when was it recovered:

Expand to all the drugs that have ingredients of fingolimod:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gilenya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Viral vasculitis:

Browse all the conditions that are associated with Viral vasculitis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod (the active ingredients of Gilenya) and Gilenya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.